Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports

Clin Drug Investig. 2022 Aug;42(8):697-701. doi: 10.1007/s40261-022-01183-1. Epub 2022 Jul 19.

Alberto Quinzii^#^{1

2}, Camilla Zecchetto^#^{1

2}, Simona Casalino^{1

2}, Marina Gaule^{1

2}, Camilla Pesoni^{1

2}, Valeria Merz^{2

3}, Serena Contarelli², Silvia Pietrobono², Karim A Benhadji⁴, Davide Melisi^{5

6}

¹ Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Policlinico "G.B. Rossi", Piazzale L.A. Scuro, 10, 37134, Verona, Italy.
² Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy.
³ Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.
⁴ Taiho Oncology, Inc., Princeton, NJ, USA.
⁵ Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Policlinico "G.B. Rossi", Piazzale L.A. Scuro, 10, 37134, Verona, Italy. davide.melisi@univr.it.
⁶ Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy. davide.melisi@univr.it.

^# Contributed equally.

No abstract available

Publication types